Technical Analysis for EYPT - EyePoint Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 2.44 -1.21% -0.03
EYPT closed down 1.21 percent on Monday, March 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Down
See historical EYPT trend table...

Date Alert Name Type % Chg
Mar 18 50 DMA Support Bullish 0.00%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 18 NR7 Range Contraction 0.00%
Mar 18 NR7-2 Range Contraction 0.00%
Mar 15 50 DMA Support Bullish -1.21%
Mar 15 NR7 Range Contraction -1.21%
Mar 15 Earnings Movers Other -1.21%
Mar 14 20 DMA Resistance Bearish -0.81%
Mar 14 Earnings Movers Other -0.81%
Mar 14 Outside Day Range Expansion -0.81%

Older signals for EYPT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases. The company's lead product is ILUVIEN for the treatment of diabetic macular edema; and product candidate is YUTIQ, a non-erodible fluocinolone acetonide insert for the treatment of non-infectious posterior uveitis that is in the Phase III clinical trials. It also offers Retisert (fluocinolone acetonide intravitreal implant), a sustained-release implant for the treatment of posterior segment uveitis. In addition, the company has developed DEXYCU (dexamethasone intraocular suspension), an intraocular product for the treatment of postoperative ocular inflammation; and Vitrasert (ganciclovir), a sustained release implant for the treatment of cytomegalovirus retinitis. Further, it develops YUTIQ shorter-actinguveitis for the treatment of posterior segment uveitis; and Durasert tyrosine kinase inhibitor for the treatment of wet age-related macular degeneration. Additionally, the company's development program focuses on developing sustained release products using its Durasert and Verisome technology platforms to deliver drugs to treat chronic diseases. It sells its products primarily in the United States and Europe. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, and Enigma Therapeutics Limited. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Watertown, Massachusetts.
Medicine Chemistry Biopharmaceutical Organic Compounds Technology Platforms Wet Age Related Macular Degeneration Glucocorticoids Macular Edema Ophthalmic Products Uveitis Chronic Diseases Diabetic Macular Edema Eye Diseases Pregnanes Alimera Sciences Cytomegalovirus Retinitis Diketones Diols
Is EYPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.94
52 Week Low 1.05
Average Volume 319,456
200-Day Moving Average 2.3404
50-Day Moving Average 2.4282
20-Day Moving Average 2.5595
10-Day Moving Average 2.474
Average True Range 0.1564
ADX 11.34
+DI 18.6184
-DI 20.4414
Chandelier Exit (Long, 3 ATRs ) 2.3508
Chandelier Exit (Short, 3 ATRs ) 2.7392
Upper Bollinger Band 2.7815
Lower Bollinger Band 2.3375
Percent B (%b) 0.23
BandWidth 17.347138
MACD Line 0.0058
MACD Signal Line 0.0292
MACD Histogram -0.0234
Fundamentals Value
Market Cap 96.06 Million
Num Shares 39.4 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -4.69
Price-to-Sales 6.21
Price-to-Book 3.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.58
Resistance 3 (R3) 2.57 2.53 2.55
Resistance 2 (R2) 2.53 2.49 2.53 2.54
Resistance 1 (R1) 2.48 2.47 2.46 2.49 2.54
Pivot Point 2.44 2.44 2.43 2.44 2.44
Support 1 (S1) 2.39 2.40 2.37 2.40 2.34
Support 2 (S2) 2.35 2.38 2.35 2.34
Support 3 (S3) 2.30 2.35 2.33
Support 4 (S4) 2.31